dr. denham on hyperprogression in patients with nsclc
Published 6 years ago • 170 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:14
dr. kim addresses concerns about hyperprogression in nsclc
-
4:04
hyperprogressive disease in lung cancer
-
7:22
tumor 'hyperprogression' after immunotherapy - medpage today
-
4:13
hyperprogressive disease in lung cancer patients treated with immunotherapy
-
0:53
dr. ferris on combining sting agonists with checkpoint inhibitors in head and neck cancer
-
4:00
cancer immunotherapy - pd-1 and pd-l1
-
14:13
tumor deconvolution dream challenge: inferring immune... - andrew gentles - recomb/rsg 2018
-
23:16
tumors of the endocrine pancreas - crash! medical review series
-
2:51
dr. fine on the utility of captem in chemo-resistant neuroendocrine tumors
-
1:02
dr. reid merryman discusses a study of checkpoint inhibitors prior to stem cell transplant
-
0:54
dr. comperat on the treatment strategy for neuroendocrine tumors
-
23:02
immunotherapy: moving beyond pd1 and pdl1 inhibitors
-
1:30
brain tumors & immune-checkpoint inhibitors
-
0:54
who is eligible for targeted and immune therapies?
-
0:58
dr. huffman on survival analysis of patients with pseudopapillary tumors of the pancreas
-
1:52
what are checkpoint inhibitors
-
6:27
immunotherapy in msi-high pancreatic tumors
-
0:48
immune checkpoint inhibitors in ovarian cancer
-
1:49
dr. sosman on checkpoint inhibitors in cancer care
-
1:31
dr. bendell on hsp90 inhibition in advanced solid tumors
-
8:04
neuroendocrine tumors: expert care
-
2:43
immunotherapy trials and hyperprogressive disease